非环核苷膦酸酯类化合物Alamifovir(MCC-478)的合成
被引量：1
出处
《贵州医药》
CAS
2008年第3期258-260,共3页
Guizhou Medical Journal
基金
贵阳医学院博士启动基金资助项目(C2006-7)
参考文献5
-
1Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepat, 2004,11: 97-107.
-
2Clercq ED. Strategies in the design of antiviral drugs. Nature Reviews[J]. Drug Discovery, 2002,1: 13-25.
-
3Zoulim F. Assessing hepatitis B virus resistance in vitro and molecular mechanisms of nucleoside resistance[J]. Seminars in Liver Disease, 2002,22: 23-31.
-
4Sekiya K, Takashima H,Ueda N. 2-Amino-6-arylthio- 9- [- 2- ( phosphono methoxy) ethyl-] purine Bis ( 2, 2, 2- trifluoroethyl) Esters as Novel HBV-Specific Antiviral Reagents[J]. Med Chem, 2002,45(14) : 3 138-3 142.
-
5Choi JT, Hwang JR. Novel phosphonate nucleosides as antiviral agents[J]. Drugs of the Future, 2004,29(2): 163-177.
同被引文献9
-
1LAVANCHY D. Hepatit is B virus epidemiology, disease hurden, treatment and current and emerging prevention and control meas- ures[J]. J ViraIHepat, 2004, 11(2) :97 -107.
-
2DE CLERCQ E. Strategies in the design of antiviral drugs[J]. Nat Rev Drug Discov, 2002, 1 (1) :13 -25.
-
3ZOULIM F. Assessing hepatitis B virus resistance in vitro and molecular mechanisms of nucleoside resistance [ J ]. Semin Liver Dis, 2002, 22(Suppl 1): 23 -31.
-
4SEKIYA K, TAKASHIMA H, UEDA N, et al. 2-Amino-6-aryl- thio-9- [ 2- ( phosphonomethoxy ) ethyl ] purine bis ( 2,2,2-trifla- oroethyl) esters as novel HBY-specific antiviral reagents[ J]. J Med Chem, 2002, 45 ( 14 ) :3138 - 3142.
-
5CHOI JT, H WANG JR. Novel phosphonate nucleosides as anti- viral agents[J]. Drugs Future, 2004, 29(2) :163 -177.
-
6FISCHER KP, GUTFREUND KS, TYRRELL DL. Lamivudine resistance in hepatitis B: mechanisms and clinical in plications [J]. Drug Resist Update, 2001, 4(2): 118-135.
-
7ONO-NITA SK, KATO N, SHIRATORI Y, et al. Novel nucleo-side analogue MCC-478 (LY582563) is effective against wild- type or lain ivudine resistant hepatitis B virus[ J].Antirnicrob A- gents Chemother, 2002, 46 ( 8 ) :2602 - 2605.
-
8KAMIYA N, KUBOTA A, IWASE Y, et al. Antiviral activities of MCC-478, a novel and specific inhibitor of hepatitis B virus [ J]. Antimicrob Agents Chemother, 2002, 46 (9) :2872 - 2877.
-
9王永广,何新华,仲伯华.阿米福韦类似物及其前药的设计、合成与生物活性[J].中国药物化学杂志,2010,20(6):484-489. 被引量：2
-
1金伟华.MCC—478显示强效抗HBV活性[J].国外药讯,2003(3):25-25.
-
2张珮瑛,田晓娟,刘钟东,蔡孟深.8-甲氧甲膦酸黄酮的合成研究[J].北京医科大学学报,1992,24(5):393-395. 被引量：7
-
3曹振环,陈新月.慢性乙型肝炎抗病毒药物新进展[J].国际流行病学传染病学杂志,2008,35(6):417-419. 被引量：13
-
4李庶心,匡先照,肖文松,张奉学,赵砚瑾,邓晓东,孙小梅.新型核苷膦酸酯类化合物的合成及其抗乙肝病毒活性研究[J].中国药物化学杂志,2007,17(6):344-347. 被引量：1
-
5Emtricitabine（恩曲他滨）[J].中国药科大学学报,2004,35(2):134-134.
-
6王林.抗病毒药emtricitabine[J].国外医学（药学分册）,2002,29(4):253-254.
-
7胡红丰.抗HIV-1药 恩曲他滨(emtricitabine)[J].世界临床药物,2003,24(12):761-761.
-
8王铮.FDA批准emtricitabine用于治疗HIV[J].国外药讯,2003(9):26-26.
-
9李雅娟（摘）.度洛西汀对肝损害的新警告[J].国外药讯,2006(3):40-40.
-
10吴松泉,顾方舟.HIV感染与硒衰竭[J].微生物学免疫学进展,1998,26(4):74-77. 被引量：3
